Maria Mancini
Chief Operating Officer presso CHAMPIONS ONCOLOGY, INC.
Profilo
Maria Mancini is Chief Operating Officer of Champions Oncology, Inc.
In her past career she was Research Director at Biomodels LLC.
Dr. Mancini received a doctorate from the University of Maine.
Posizioni attive di Maria Mancini
Società | Posizione | Inizio |
---|---|---|
CHAMPIONS ONCOLOGY, INC. | Chief Operating Officer | - |
Precedenti posizioni note di Maria Mancini
Società | Posizione | Fine |
---|---|---|
Biomodels LLC
Biomodels LLC BiotechnologyHealth Technology Biomodels LLC offers customized solutions for the development of disease models in the fields of biology, behavior, and neuroscience. Biomodels is based in Boston, MA and was founded in 1997 with the aim of creating a more useful interface between leading academic researchers and the pharmaceutical industry. The private company provides a wide range of behavioral tests for examining treatment for neurological disorders. The company has developed several models of fibrosis to reflect common inflammatory diseases. The company also offers in vitro models for drug response assessment, metabolic disease studies, microbiome research services, and preclinical research services for cancer, radiation countermeasures, and inflammatory diseases. | Chief Tech/Sci/R&D Officer | 01/03/2015 |
Formazione di Maria Mancini
University of Maine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CHAMPIONS ONCOLOGY, INC. | Health Technology |
Aziende private | 1 |
---|---|
Biomodels LLC
Biomodels LLC BiotechnologyHealth Technology Biomodels LLC offers customized solutions for the development of disease models in the fields of biology, behavior, and neuroscience. Biomodels is based in Boston, MA and was founded in 1997 with the aim of creating a more useful interface between leading academic researchers and the pharmaceutical industry. The private company provides a wide range of behavioral tests for examining treatment for neurological disorders. The company has developed several models of fibrosis to reflect common inflammatory diseases. The company also offers in vitro models for drug response assessment, metabolic disease studies, microbiome research services, and preclinical research services for cancer, radiation countermeasures, and inflammatory diseases. | Health Technology |